Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

aTyr Pharma, Inc. - Common Stock (NQ:ATYR)

0.8078 +0.0370 (+4.80%)
Streaming Delayed Price Updated: 10:52 AM EST, Dec 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about aTyr Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
ATYR Investors: Securities Law Firm Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against aTyr Pharma, Inc.
From Robbins LLP
Via GlobeNewswire
News headline image
Contact Levi & Korsinsky by December 8, 2025 Deadline to Join Class Action Against aTyr Pharma, Inc. (ATYR)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Contact Levi &amp; Korsinsky by December 8, 2025 Deadline to Join Class Action Against aTyr Pharma, Inc. (ATYR)
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Class Action Filed Against aTyr Pharma, Inc. (ATYR) Seeking Recovery for Investors - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Class Action Filed Against aTyr Pharma, Inc. (ATYR) Seeking Recovery for Investors - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky for More Information - ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Levi & Korsinsky Reminds aTyr Pharma, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Levi &amp; Korsinsky Reminds aTyr Pharma, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
ATYR PHARMA INC (NASDAQ:ATYR) Shares Slide After Q3 Revenue and EPS Miss Estimates ↗
aTyr Pharma's Q3 2025 results missed revenue and EPS estimates. Investors now focus on the upcoming 2026 FDA meeting for its lead drug, efzofitimod. 
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at aTyr Pharma
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Levi & Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Levi &amp; Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2025 - ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Shareholders That Lost Money on aTyr Pharma, Inc. (ATYR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Shareholders That Lost Money on aTyr Pharma, Inc. (ATYR) Urged to Join Class Action - Contact Levi &amp; Korsinsky to Learn More
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
December 8, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ATYR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
December 8, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Levi &amp; Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.